These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36272020)

  • 1. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
    Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
    Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
    Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
    Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
    El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
    Front Immunol; 2021; 12():643170. PubMed ID: 33732263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
    Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
    Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of miR-20a-5p in mesenchymal stem cell derived-exosomes from systemic lupus erythematosus patients restored therapeutic effect and Treg immune regulation.
    Ji J; Liang Q; He Q; Chen T; Feng G; Guo H; Wang Y; Xu Y; Chen P; Dong C; Zhao R; Yang J; Sha X; Cao H; Li J; Xia Y; Yang M; Gu Z
    Eur J Pharmacol; 2024 Sep; 979():176862. PubMed ID: 39068974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus.
    Xu L; Dai Q; Zhang Y; Lin N; Ji L; Song X
    Cell Transplant; 2024; 33():9636897241236586. PubMed ID: 38469823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus.
    Geng L; Tang X; Wang S; Sun Y; Wang D; Tsao BP; Feng X; Sun L
    Front Immunol; 2020; 11():233. PubMed ID: 32133007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
    Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
    Front Immunol; 2021; 12():728190. PubMed ID: 34659214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
    Xu J
    Adv Exp Med Biol; 2018; 1089():73-85. PubMed ID: 29767288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
    Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
    IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.
    Chun S; Choi CB; Kim MS; Nam JY; Lee TY; Lee YT; Kim S; Han SB; Bae SC
    Lupus; 2022 Sep; 31(10):1245-1253. PubMed ID: 35802867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus.
    Zhu Y; Feng X
    Stem Cell Res Ther; 2018 May; 9(1):149. PubMed ID: 29793537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2.
    Zhang Z; Huang S; Wu S; Qi J; Li W; Liu S; Cong Y; Chen H; Lu L; Shi S; Wang D; Chen W; Sun L
    EBioMedicine; 2019 Jul; 45():341-350. PubMed ID: 31248835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
    Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
    Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A State-of-the-Art Review on the Recent Advances of Mesenchymal Stem Cell Therapeutic Application in Systematic Lupus Erythematosus.
    Karimi F; Nejati B; Rahimi F; Alivirdiloo V; Alipourfard I; Aghighi A; Raji-Amirhasani A; Eslami M; Babaeizad A; Ghazi F; Firouzi Amandi A; Dadashpour M
    Immunol Invest; 2024 Feb; 53(2):160-184. PubMed ID: 38031988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder.
    Fathollahi A; Gabalou NB; Aslani S
    Lupus; 2018 Jun; 27(7):1053-1064. PubMed ID: 29631514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-bone marrow mesenchymal stem cell transplantation modulates myeloid bias tendency of hematopoietic stem and progenitor cells in severe MRL/lpr lupus mice.
    Hang Y; Chen Y; Huang M; Wen X; Zhou P; Zhu R; Wang R; Ding S; Sun L
    Int Immunopharmacol; 2024 Aug; 137():112427. PubMed ID: 38889506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone-Integrated Mesenchymal Stem Cells for Systemic Lupus Erythematosus Treatment
    Ma W; Che J; Chen W; Wang D; Zhang H; Zhao Y
    ACS Nano; 2024 May; 18(20):13249-13265. PubMed ID: 38720584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.